News Quantified

LQDA – liquidia corporation (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Arquitos Epicus 2025 Shareholder Letter [Seeking Alpha]

Liquidia to Present Clinical Data Across Its Portfolio at the Pulmonary Vascular Research Institute 2026 Annual Congress

Liquidia: Capturing Special Situation Gains And Longer-Term Gains [Seeking Alpha]

Arquitos Capital Q4 2025 Investor Letter [Seeking Alpha]

Liquidia (NASDAQ:LQDA) was downgraded by analysts at Wall Street Zen

-6.6%

BEAT

6.5%

MISS

0.6%

MISS

Form 4 Liquidia Corp For: Jan 26 Filed by: Boyle Dana

Form 4 Liquidia Corp For: Jan 26 Filed by: Adair Jason

Form 4 Liquidia Corp For: Jan 16 Filed by: Adair Jason

Form 4 Liquidia Corp For: Jan 16 Filed by: Boyle Dana

Form 4 Liquidia Corp For: Jan 16 Filed by: JEFFS ROGER

Top News Gainers

12/26 Liquidia Technologies Inc (NASDAQ: LQDA) had its "buy" rating re-affirmed by analysts at Wedbush. They now have a $37.00 price target on the stock. 43.5%

4/3 Form 4 Liquidia Technologies For: Apr 01 Filed by: Eshelman Ventures, LLC 25.0%

1/10 Form 4 Liquidia Technologies For: Dec 27 Filed by: Canaan VIII LP 22.5%

4/7 Form 4 Liquidia Technologies For: Apr 03 Filed by: Eshelman Ventures, LLC 17.1%

1/15 Liquidia Technologies Inc (NASDAQ: LQDA) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $6.25 price target on the stock. 14.0%

12/24 Liquidia Technologies Announces $22.4 Million Private Placement 12.5%

8/8 Q2/2019 6/30/2019 EPS -0.320 ZacksConsensus -0.570 ActVsEst 0.250 - Beat 9.6%

11/13 Q3/2019 9/30/2019 EPS -0.720 ZacksConsensus -0.520 ActVsEst (0.200) - Miss 8.5%

8/23 Form S-3 Liquidia Technologies 7.8%

3/20 Form 8-K Liquidia Technologies For: Mar 18 7.5%

Top News Decliners

9/3 Liquidia to Present at H.C. Wainwright Healthcare Conference -18.6%

8/26 Form 4 Liquidia Technologies For: Aug 22 Filed by: Albury Timothy -17.6%

4/20 Form SEC STAFF LETTER Liquidia Technologies -14.8%

11/6 Liquidia to Report Third Quarter 2019 Financial Results and Provide Corporate Update on November 13, 2019 -14.6%

2/26 Liquidia to Present at Cowen 40th Annual Health Care Conference -13.3%

12/31 Liquidia Technologies Inc (NASDAQ: LQDA) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -11.1%

4/30 Liquidia Releases Final LIQ861 Results from Pivotal Phase 3 INSPIRE Study in Patients with Pulmonary Arterial Hypertension -9.9%

1/24 Liquidia Announces Poster Presentation at the 14th Annual World Congress of the Pulmonary Vascular Research Institute (PVRI) -8.8%

6/5 Liquidia Announces Clinical Update on INSPIRE; Targeting NDA Filing for LIQ861 in Late 2019 -8.4%

4/8 Liquidia Technologies Inc (NASDAQ: LQDA) had its price target raised by analysts at Wedbush from $37.00 to $41.00. They now have an "outperform" rating on the stock. -8.3%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day